TY - JOUR
T1 - Er–mitochondria calcium flux by β-sitosterol promotes cell death in ovarian cancer
AU - Bae, Hyocheol
AU - Park, Sunwoo
AU - Ham, Jiyeon
AU - Song, Jisoo
AU - Hong, Taeyeon
AU - Choi, Jin Hee
AU - Song, Gwonhwa
AU - Lim, Whasun
N1 - Funding Information:
Funding: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1A2C2089914, 2020R1I1A1A01067648, 2021R1A2C2005841, and 2021R1C1C1009807)
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/10
Y1 - 2021/10
N2 - Phytosterols, which are derived from plants, have various beneficial physiological effects, including anti-hypercholesterolemic, anti-inflammatory, and antifungal activities. The anticancer activities of natural products have attracted great attention, being associated with a low risk of side effects and not inducing antineoplastic resistance. β-sitosterol, a phytosterol, has been reported to have anticancer effects against fibrosarcoma and colon, breast, lung, and prostate cancer. However, there are no reports of its activity against ovarian cancer. Therefore, we investigated whether β-sitosterol shows anticancer effects against ovarian cancer using human ovarian cancer cell lines. We confirmed that β-sitosterol induced the apoptosis of ovarian cancer cells and suppressed their pro-liferation. It triggered pro-apoptosis signals and the loss of mitochondrial membrane potential, en-hanced the generation of reactive oxygen species and calcium influx through the endoplasmic re-ticulum–mitochondria axis, and altered signaling pathways in human ovarian cancer cells. In addi-tion, we observed inhibition of cell aggregation, suppression of cell growth, and decreased cell mi-gration in ovarian cancer cells treated with β-sitosterol. Further, our data obtained using ovarian cancer cells showed that, in combination with standard anti-cancer drugs, β-sitosterol demonstrated synergistic anti-cancer effects. Thus, our study suggests that β-sitosterol may exert anti-cancer effects against ovarian cancer in humans.
AB - Phytosterols, which are derived from plants, have various beneficial physiological effects, including anti-hypercholesterolemic, anti-inflammatory, and antifungal activities. The anticancer activities of natural products have attracted great attention, being associated with a low risk of side effects and not inducing antineoplastic resistance. β-sitosterol, a phytosterol, has been reported to have anticancer effects against fibrosarcoma and colon, breast, lung, and prostate cancer. However, there are no reports of its activity against ovarian cancer. Therefore, we investigated whether β-sitosterol shows anticancer effects against ovarian cancer using human ovarian cancer cell lines. We confirmed that β-sitosterol induced the apoptosis of ovarian cancer cells and suppressed their pro-liferation. It triggered pro-apoptosis signals and the loss of mitochondrial membrane potential, en-hanced the generation of reactive oxygen species and calcium influx through the endoplasmic re-ticulum–mitochondria axis, and altered signaling pathways in human ovarian cancer cells. In addi-tion, we observed inhibition of cell aggregation, suppression of cell growth, and decreased cell mi-gration in ovarian cancer cells treated with β-sitosterol. Further, our data obtained using ovarian cancer cells showed that, in combination with standard anti-cancer drugs, β-sitosterol demonstrated synergistic anti-cancer effects. Thus, our study suggests that β-sitosterol may exert anti-cancer effects against ovarian cancer in humans.
KW - 3D spheroid
KW - Apoptosis
KW - ER-mitochondria calcium flux
KW - Ovarian cancer
KW - β-sitosterol
UR - http://www.scopus.com/inward/record.url?scp=85116581883&partnerID=8YFLogxK
U2 - 10.3390/antiox10101583
DO - 10.3390/antiox10101583
M3 - Article
AN - SCOPUS:85116581883
SN - 2076-3921
VL - 10
JO - Antioxidants
JF - Antioxidants
IS - 10
M1 - 1583
ER -